Europe Research Roundup: Alfen, Argenx, JDE Peet's
Aug 25 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Alfen, Argenx, and JDE Peet's on Monday. HIGHLIGHTS
| * Alfen NV ALFEN.AS: ING cuts target price to EUR 10 from EUR 12.5 |
| * Argenx SE ARGX.BR: Degroof Petercam raises target price to EUR 776 from EUR 756 |
| * JDE Peet'S JDEP.AS: JP Morgan raises to neutral from underweight |
| * Alfen NV ALFEN.AS: ING cuts target price to EUR 10 from EUR 12.5 |
| * Argenx SE ARGX.BR: Degroof Petercam raises target price to EUR 776 from EUR 756 |
| * Hornbach Holding AG & Co KGaA HBH.DE: Baader Helvea raises PT to EUR 118 from EUR 95 |
| * JDE Peet'S JDEP.AS: JP Morgan raises to neutral from underweight |
| * JDE Peet'S JDEP.AS: JP Morgan raises target price to EUR 31.85 from EUR 20.5 |
| * UCB SA UCB.BR: Degroof Petercam raises to buy rating; raises PT to EUR 244 from EUR 196 |
Recent news on argenx SE
See all newsArgenx falls after Vyvgart trial update on myositis drug, brokers remain positive
Brief: ArgenX Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit In Myositis And Sjogren’S Disease
Brief: argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
Brief: Argenx Q1 Total Operating Income USD 1.313 Bln
Netherlands' Argenx Q1 net sales rise 63%, profit more than doubles